ClinicalTrials.gg
RecruitingNCT06861998Updated May 28, 2025

Preoperative Sleep Intervention on Postoperative Delirium in Infants and Toddlers Undergoing Congenital Heart Surgery

An interventional study of Message-based bedtime routine and sleep hygiene education in Delirium - Postoperative, Sleep Problems and Congenital Heart Disease (CHD), sponsored by Yan Fuxia. Recruiting at 1 site in China. Open to participants aged 1 Day to 3 Years. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Yan Fuxia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
452
Allocation
Randomized
Ages
1 Day to 3 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 185 studies in Emergence Delirium with a site in China — 64 open to participants now, 65 under way, 1 of them phase 3. Emergence Delirium · China.

Planned enrollment
28th of 111
452 · median 225
Started
2025
with 20 others
No phase
70 of 185
29 open now
Primary completion
2025-12
later than 17 of 64 live
Registered
133rd of 185
by date

Among the 185 studies in Emergence Delirium with a site in China, this one is the 28th largest by planned enrollment of the 111 interventional ones that give a count, is one of 21 that started in 2025, is one of 70 with no phase, reaches primary completion later than 17 of the 64 other live ones, and was the 133rd registered.

Emergence Delirium

752 studies on the registry are indexed under Emergence Delirium; 262 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

64 of the 185 studies in Emergence Delirium with a site in China are open now. Recruiting first, the newest first:

58 more — sign in →

All 64 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 143 Emergence Delirium studies recruiting now, 79 (55%) set no upper age limit and 44 (31%) stop at 75 or younger; 34 take children under 18; 24 take healthy volunteers.

This study: 1 Day to 3 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Emergence Delirium with a site in China, or all of them as a file.
02

Study summary

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered infants and toddlers undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Brief Infant Sleep Questionnaire (BISQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received sleep hygiene education and a bedtime routine based on touch, the control group received only sleep hygiene education. The primary outcome is the incidence of postoperative delirium within 7 days after surgery or before discharge, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Read the detailed description

The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics.

The research process is as follows: Perform routine sleep disorder assessments on pediatric patients visiting the outpatient clinic. Fully inform the guardians of pediatric patients with sleep disorders of all the contents and procedures of this trial. After obtaining informed consent comprehensively and having the informed consent forms signed, conduct further assessments on the pediatric patients to determine whether they meet the inclusion and exclusion criteria. All enrolled children's guardians will receive sleep hygine education in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the children in the experimental group receive behavioral interventions every day before surgery, specifically a bedtime routine based on massage/stroking. Guardians need to strictly implement it and cooperate with the researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). In the control group, parents are provided with sleep hygiene education for infants and toddlers, and no additional intervention measures are applied. To better control the quality of interventions for children aged 0 - 3 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, they fill out the Brief Infant Sleep Questionnaire (BISQ) again and compare it with the baseline situation. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.

03

Conditions studied

  • Delirium - Postoperative
  • Sleep Problems
  • Congenital Heart Disease (CHD)
04

Who can participate

Ages eligible
1 Day to 3 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 0-3 years
  2. Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
  3. Children with sleep disorders who are screened by the Brief Infant Sleep Questionnaire-Revised short form (BISQ-R SF).

Exclusion criteria

Exclusion Criteria:

  1. Infants and toddlers who have taken any relevant preoperative treatment for sleep problems
  2. The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4.
  3. Preoperative history of cerebral ischemia and hypoxia, developmental disorders such as autism spectrum disorders, etc.
  4. Presence of any other preoperative acute or chronic medical condition (mechanical ventilation support, history of asphyxia rescue, severe hepatic or renal dysfunction, or comorbidities with other non-cardiac malformations)
  5. Concurrent participation in other clinical trials
  6. Refusal of the family to sign the or poor compliance of the child.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
452 participants (estimated)

Study arms

  • Experimental
    Message-based bedtime routine group

    The intervention group implemented sleep hygiene education and the Message-based bedtime routine, including nutritional activities-hygiene-communication-message.

    Behavioral: Message-based bedtime routine

  • Other
    Sleep hygiene education group

    The control group received only sleep hygiene education.

    Behavioral: sleep hygiene education

Interventions

  • BehavioralMessage-based bedtime routine

    The intervention group implemented sleep hygiene education and the Message-based bedtime routine, including nutritional activities-hygiene-communication-message.

  • Behavioralsleep hygiene education

    Sleep hygiene education includes sleep environment, sleeping location, regular sleep schedule, bedtime routines, sleeping methods, and sleeping posture.

06

What researchers measure

Primary outcomes

  1. The incidence of postoperative delirium

    Time frame: Postoperative 7 days

Secondary outcomes

  1. Mechanistic endpoint: Concentration of plasma S-100β protein

    S-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  2. Postoperative sleep quality

    Postoperative sleep quality was assessed using the Actigraph model wGT3X-BT body movement recorder. The Actigraph model wGT3X-BT was worn from the time of admission to 7 days after surgery in order to assess the sleep quality of the subjects.

    Time frame: Postoperative 7 days or before discharge

  3. Pain defined by the Face, Legs, Activity, Cry, and Consolability scale

    The FLACC scale is a simple and effective tool used to assess pain in infants and non-verbal patients. It stands for Face, Legs, Activity, Cry, and Consolability. Each of these five items is scored on a scale of 0 to 2, with a higher score indicating a greater degree of pain. The total FLACC score, ranging from 0 to 10, provides a quick and reliable assessment of the patient's pain level.

    Time frame: Postoperative 7 days

  4. The incidence of postoperative Acute kidney injury

    Time frame: Within postoperative 7 days

  5. The incidence of Pulmonary complication

    Time frame: Postoperative 7 days

  6. The incidence of postoperative Liver dysfunction

    Time frame: Postoperative 7 days

  7. Concentration of intestinal fatty acid binding protein (I-FABP)

    one of markers of intestinal injury

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  8. Concentration of zonulin

    One of markers of intestinal injury

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  9. Concentration of lipopolysaccharide (LPS)

    One of markers of intestinal injury

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  10. Concentration of lipopolysaccharide binding protein (LBP)

    One of markers of intestinal injury

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  11. Types and dosages of drugs used for postoperative sedation and analgesia

    Time frame: Postoperative 7 days or before discharge

  12. Levels of inflammatory cytokines

    The inflammatory cytokines include IL-6,TNF-α,IL-1β,IFN-γ,IL-17, C-reactive protein.

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  13. Neutrophil-to-lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR)

    Neutrophil-to-lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) are two blood biomarkers based on blood cell counts, which reflect the inflammatory and immune status of the body; they were obtained based on preoperative and postoperative blood routine tests.

    Time frame: Before surgery, 24 hours after surgery

  14. The duration of postoperative mechanical ventilation

    The total hours needing mechanical ventilation support

    Time frame: From the end of the surgery to discharge from the hospital,up to 30 days

  15. The length of intensive care unit stay

    The time spent in the intensive care unit.

    Time frame: From the end of the surgery to discharge from the hospital,up to 30 days

  16. The length of postoperative hospital stay

    Time frame: From the end of the surgery to the day of discharge from the hospital,up to 30 days

  17. Average daily cost

    total hospitalization cost divided by total length of stay

    Time frame: admission to discharge, up to 30days

Other outcomes

  1. Long-term Sleep quality score

    guardians scored sleep quality 1-5 using a sleep diary

    Time frame: 30 days, 6 months, 1 year after discharge

  2. Readmission rate

    the rate at which a patient is readmitted to the hospital for the same or a different health problem within 30 days/six months/1 year after discharge

    Time frame: 30 days/6 months/1 year after discharge

  3. 1-Year Mortality and Survival

    The rate at which patients die and survive within 1 year of discharge from the hospital.

    Time frame: 1 year after discharge

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Dec 2025, 8 months after the start.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2025
First posted
Mar 6, 2025
StartActual
Apr 30, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
May 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06861998
Lead sponsor
Yan Fuxia
Responsible party
Yan Fuxia (principal investigator, Chinese Academy of Medical Sciences, Fuwai Hospital) — Sponsor-investigator
First posted
Mar 6, 2025
Start date
Apr 30, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 28, 2025

Study contacts

Fuxia Yan
Contact
yanfuxia@sina.com
010-88396628
Fuxia Yan
principal investigator · Chinese Academy of Medical Sciences, Fuwai Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion